156 related articles for article (PubMed ID: 28875507)
41. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
42. [Frequency of genetic aberrations in mucosa-associated lymphoid tissue lymphoma of different sites].
Li BZ; Lu HF; Zhou XY; Yang WT; Kong YY; Fan YZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):604-8. PubMed ID: 19094584
[TBL] [Abstract][Full Text] [Related]
43. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
45. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy.
Illes A; Varoczy L; Papp G; Wilson PC; Alex P; Jonsson R; Kovacs T; Konttinen YT; Zeher M; Nakken B; Szodoray P
Scand J Immunol; 2009 May; 69(5):387-400. PubMed ID: 19508370
[TBL] [Abstract][Full Text] [Related]
46. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
Rodig SJ; Abramson JS; Pinkus GS; Treon SP; Dorfman DM; Dong HY; Shipp MA; Kutok JL
Clin Cancer Res; 2006 Dec; 12(23):7174-9. PubMed ID: 17145843
[TBL] [Abstract][Full Text] [Related]
48. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.
Krenács D; Borbényi Z; Bedekovics J; Méhes G; Bagdi E; Krenács L
Virchows Arch; 2015 Sep; 467(3):345-55. PubMed ID: 26089142
[TBL] [Abstract][Full Text] [Related]
49. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma.
Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; De La Red G; Gil V; López-Guillermo A; Ingelmo M; Font J
J Rheumatol; 2004 Mar; 31(3):495-9. PubMed ID: 14994393
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of protein kinase C beta(2) expression in lymphoid malignancies.
Decouvelaere AV; Morschhauser F; Buob D; Copin MC; Dumontet C
Histopathology; 2007 Apr; 50(5):561-6. PubMed ID: 17394491
[TBL] [Abstract][Full Text] [Related]
51. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.
Walsh SH; Rosenquist R
Med Oncol; 2005; 22(4):327-41. PubMed ID: 16260850
[TBL] [Abstract][Full Text] [Related]
52. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
53. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
O'Malley DP; Auerbach A; Weiss LM
Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
[TBL] [Abstract][Full Text] [Related]
54. Malignant lymphoma of the lacrimal gland: a nation-based study.
Rasmussen P; Ralfkiaer E; Prause JU; Sjö LD; Siersma VD; Heegaard S
Arch Ophthalmol; 2011 Oct; 129(10):1275-80. PubMed ID: 21987669
[TBL] [Abstract][Full Text] [Related]
55. Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis.
Sugita Y; Muta H; Ohshima K; Morioka M; Tsukamoto Y; Takahashi H; Kakita A
Neuropathology; 2016 Aug; 36(4):313-24. PubMed ID: 26607855
[TBL] [Abstract][Full Text] [Related]
56. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
[TBL] [Abstract][Full Text] [Related]
57. Flow Cytometry in the Diagnosis of Canine B-Cell Lymphoma.
Riondato F; Comazzi S
Front Vet Sci; 2021; 8():600986. PubMed ID: 33869314
[TBL] [Abstract][Full Text] [Related]
58. Antigens in lymphoma development--current knowledge and future directions.
Rosenquist R; Davi F; Stamatopoulos K
Semin Cancer Biol; 2013 Dec; 23(6):397-8. PubMed ID: 24080344
[TBL] [Abstract][Full Text] [Related]
59. The tumour microenvironment in B cell lymphomas.
Scott DW; Gascoyne RD
Nat Rev Cancer; 2014 Aug; 14(8):517-34. PubMed ID: 25008267
[TBL] [Abstract][Full Text] [Related]
60. Murine models of B-cell lymphomas: promising tools for designing cancer therapies.
Donnou S; Galand C; Touitou V; Sautès-Fridman C; Fabry Z; Fisson S
Adv Hematol; 2012; 2012():701704. PubMed ID: 22400032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
